Agape ATP upsizes proposed offering to $7m, seeks Nasdaq uplisting

Must read

Gilead Sciences on track to snap its six-day winning streak

Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....

AbbVie shares set for seventh straight session of gains

AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...

Meta Platforms on track to snap six-day red streak

Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....

Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)

Scott Olson/Getty Images News Update 1:35pm: Updates shares, adds court hearing ended. Kenvue Inc. (NYSE:KVUE), the consumer health company...
Initial public offering hologram, night panoramic city view of Bangkok. The financial center for multinational corporations in Asia. The concept of boosting the growth by IPO process. Double exposure.

2d illustrations and photos

Agape ATP (OTCPK:AATP), which is seeking to uplist to Nasdaq, has upsized its proposed public offering to around $7M.

Agape ATP said in a filing that it is now looking to offer 1.1M shares priced between $5.50 to $6.50, which would raise $6.6M if priced at the midpoint. Underwriters would be granted a 45-day option to buy up to 165K additional shares to cover over-allotments.

In a filing in June, Agape said that it was seeking to raise around $4.4M by offering 730K shares in the same price range. EF Hutton was to serve as bookrunner.

Agape’s shares are currently traded OTC. The company hopes to uplist them to Nasdaq under the symbol ATPC. Network 1 Securities is serving as bookrunner on the deal.

Based in Kuala Lumpur, Agape is a provider of health and wellness products and services in Malaysia.

More articles

Latest article

Gilead Sciences on track to snap its six-day winning streak

Shares of Gilead Sciences (NASDAQ:GILD) were on track to end their six-day gaining streak on Thursday, noting their first decline since November 29....

AbbVie shares set for seventh straight session of gains

AbbVie (NYSE:ABBV) shares were on track for their seventh consecutive session of gains on Thursday, as the stock rose nearly 1% to 147.54...

Meta Platforms on track to snap six-day red streak

Meta Platforms' (NASDAQ:META) shares are on track to break a 6-day losing streak after losing about 4.4% over the last 6 trading sessions....

Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)

Scott Olson/Getty Images News Update 1:35pm: Updates shares, adds court hearing ended. Kenvue Inc. (NYSE:KVUE), the consumer health company...

FedEx shares on track to record its seventh straight session of gains

Sundry Photography/iStock Editorial via Getty Images Global delivery firm FedEx (NYSE:FDX) shares are on track to record its seventh...